• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA


The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index



Number of results: 18

ItemProgramOfficeStrategic PlanStrategic Goal/Area
1Evaluation of Standardized Risk Benefit InformationACAN/AN/AN/A
2Assist the Access Board in Developing Accessibility StandardsACAN/AN/AN/A
3Implement Section 4205 of the Patient Protection and Affordable Care Act – Nutrition Labeling of Standard Menu Items for Chain Restaurants, Similar Retail Food Establishments and Vending MachinesACAN/AN/AN/A
4Cumulative percent of CDRH staff and reviewers trained in new accessibility criteria at the end of the monthACAN/AN/AN/A
5Provide information to women and health care providers on those areas in which differences between men and women existACAN/AN/AN/A
6Women's Participation in Clinical TrialsACAN/AN/AN/A
7Establish an abbreviated regulatory review pathway for biosimilar and interchangeable biological productsACAN/AN/AN/A
8Number of outreach activities to generate awareness regarding the FDA's minority health activitiesACAN/AN/AN/A
9Number of Departmental meetings in the month related to ACA implementationACAN/AN/AN/A
10Cumulative number of visits to new FDA minority health webpage in the monthACAN/AN/AN/A
11Number of external FDA stakeholder meetings in the monthACAN/AN/AN/A
12Number of outreach activities to promote FDA advisory committee vacanciesACAN/AN/AN/A
13Number of inquiries by FDA Centers for Advisory Committee vacanciesACAN/AN/AN/A
14Ensure that the Office of Minority Health meets the requirements set out in the Affordable Care ActACAN/AN/AN/A
15Office of Minority Health Infrastructure DevelopmentACAN/AN/AN/A
16Strengthen FDA capacity to address minority health and health disparities across the AgencyACAN/AN/AN/A
17Strengthen Regulatory Science/Health Disparities Research InitiativesACAN/AN/AN/A
18Implement new ANDA labeling change provisionsACAN/AN/AN/A

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.